Multiple Sclerosis Correlations Between Changes In Disability And T2-Weighted Brain MRI Activity

A Follow-Up Study

Filippi M, Paty DW, Kappos L, Barkhof F, Compston DA, Thompson AJ, Zhao GJ, Wiles CM, McDonald WI, Miller DH
Neurology 1995 Feb 45:2 255-60
Institute of Neurology, NMR Research Unit, London, UK

Abstract

We obtained two conventional unenhanced T2-weighted Brain MRI scans, separated by an interval of 24 to 36 months, in 281 patients with Multiple Sclerosis (MS).

At the time of each scan, clinical disability was rated using the Kurtzke Expanded Disability Status Scale (EDSS).

Changes in disability between the two examinations correlated weakly but significantly with the number of new (Spearman's rank correlation coefficient = 0.13; p = 0.02) and enlarging (Spearman's rank correlation coefficient = 0.18; p = 0.002) MRI lesions.

This result suggests that Brain T2-weighted MRI is a useful supplementary marker of disease activity in definitive (Phase III) clinical treatment trials in MS.

Medical Texts
Anatomy | Immune System | Lymphocytes | Meds
MHC | Movement | Cranial Nerves | Physiology

MS Glossary ThJuland's MSers' Glen - Our CyberHome Page Top The Glen's Gallery: Come & Share Our Stories MS Files MS Abstracts Site Index

Abstracts
ANS | Bladder | Cognition | Fatigue | Fluid | Genetics
Interferons | IVIG | Nitric Oxide | Optic Neuritis | Pain
Physiology | Prions | Prognosis | ReMyelinate | Steroids
Stress | Treatments | TNF | Uric Acid | Viruses

© Copyright 1997 - 2010:
Permission is granted to MS Societies and all MSers to utilize information from these pages provided that no financial reward is gained and attribution is given to the author/s.